Clinical Trials on Relapsed/ Refractory T-cell Malignancies
Total 5270 results
-
Ruijin HospitalThe First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaboratorsRecruiting
-
Ruijin HospitalRecruiting
-
Hospices Civils de LyonRecruitingPeripheral T Cell LymphomaFrance
-
Sun Yat-sen UniversityRecruiting
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
University of Michigan Rogel Cancer CenterBristol-Myers SquibbCompletedPeripheral T Cell LymphomaUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Solasia Pharma K.K.CompletedPeripheral T-Cell LymphomaHong Kong, Japan, Taiwan, Korea, Republic of
-
HUYABIO International, LLC.Quintiles, Inc.CompletedPeripheral T-Cell Lymphoma (PTCL)Japan, Korea, Republic of
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedPeripheral T-Cell Lymphoma (PTCL)United States
-
Shandong New Time Pharmaceutical Co., LTDUnknownPeripheral T Cell Lymphoma
-
Beijing Tongren HospitalUnknown
-
Sun Yat-sen UniversityTerminatedLymphoma, Extranodal NK-T-CellChina
-
National Cancer Institute (NCI)Completed
-
Yuankai ShiUnknownPeripheral T Cell Lymphoma
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.CompletedLymphoma, T-Cell, CutaneousUnited States
-
Yale UniversityEisai Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
University of AarhusNordic Lymphoma GroupCompletedPeripheral T-Cell LymphomaNorway, Finland, Denmark
-
McGill UniversityUnknownCutaneous T-Cell LymphomaCanada
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand PharmaceuticalsCompleted
-
Associazione Angela Serra per la ricerca sul cancroRecruitingPeripheral T-Cell LymphomaUnited States, Italy, Romania, Ukraine
-
National Cancer Institute (NCI)RecruitingImmune System Diseases | Lymphoproliferative Disorders | Peripheral T-cell LymphomasUnited States
-
Kyowa Kirin, Inc.CompletedCutaneous T-Cell LymphomaUnited States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedExtranodal NK-T-Cell Lymphoma, Nasal TypeChina
-
Novartis PharmaceuticalsCompletedCutaneous T-Cell LymphomaItaly, Spain, Belgium, Canada, Australia, Germany, Switzerland, United States, France, Argentina, Finland, Hungary
-
Novartis PharmaceuticalsTerminatedCutaneous T-Cell LymphomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
University of California, San FranciscoWashington University School of Medicine; Eisai Inc.TerminatedPeripheral T-Cell LymphomaUnited States
-
University of Alabama at BirminghamSeagen Inc.; Kyowa Kirin, Inc.RecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
Eisai Inc.Dr. Reddy's Laboratory; Citius PharmaceuticalsCompletedPersistent or Recurrent Cutaneous T-Cell LymphomaUnited States, Australia, Puerto Rico
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.The First Affiliated Hospital of Zhengzhou UniversityUnknownAcute Lymphocytic Leukemia | T-lymphoblastic Lymphoma | NK/T Cell LymphomaChina
-
Washington University School of MedicineMerck Sharp & Dohme LLCWithdrawnHuman T-cell Leukemia Virus Type 1 Infection
-
Stanford UniversityTerminatedCutaneous T-cell Lymphoma | Cutaneous LymphomaUnited States
-
Rennes University HospitalCompletedHypertriglyceridemia | Cutaneous T Cell LymphomaFrance
-
SoligenixCompletedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States
-
Moleculin Biotech, Inc.CompletedCutaneous T-Cell Lymphoma/Mycosis FungoidesPoland
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Belgium
-
Fundamenta Therapeutics, Ltd.The First Affiliated Hospital of University of Science and Technology of...RecruitingT-Acute Lymphoblastic Leukemia | T-cell Non-Hodgkin Lymphoma | T-cell Acute Lymphoblastic LymphomaChina
-
Portola PharmaceuticalsWithdrawnAITL | Peripheral T-Cell Lymphoma (PTCL NOS) | Nodal Lymphomas of T Follicular Helper (TFH) | Follicular T-cell Lymphoma (FTCL) | ALCL | HSTCL | EATL I,II | MEITL, EATL Type II | Nasal Lymphoma
-
National Cancer Institute (NCI)TerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage II Cutaneous T-cell Non-Hodgkin LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
Northwestern UniversityNational Cancer Institute (NCI); CelgeneActive, not recruitingPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous... and other conditionsUnited States
-
New York Medical CollegeUniversity of Alabama at BirminghamRecruitingPeripheral T Cell Lymphoma | NK-Cell Lymphoma | NK-Cell LeukemiaUnited States
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingNewly Diagnosed Peripheral T-cell LymphomaChina
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedPreviously Untreated Peripheral T-cell LymphomaUnited States
-
SoligenixCompleted